



　Recommended guidelines pertaining to pulmonary 
rehabilitation for patients with respiratory disease 
have been developed by the American College of Chest 
Physicians/ American Association of Cardiovascular 
and Pulmonary Rehabilitation （ACCP/AACVPR） （joint） 
in 2007, the British Thoracic Society （BTS） in 2013, 
and, the American Thoracic Society and European 
Respiratory Society （ATS/ERS） （joint） in 2013, 
respectively1-3）. In Japan, a pulmonary rehabilitation 
manual developed by the four associations （the Japan 
Society for Respiratory Care and Rehabilitation; the 
Japanese Respiratory Society; the Japanese Association 
of Rehabilitation Medicine; and Japanese Physical 
Therapy Association） was published in 2012.
　Endurance training （also referred to as aerobic 
training） is the cornerstone of pulmonary rehabilitation 
programs. The BTS 2013 pulmonary rehabilitation 
guidelines state that high-intensity exercise training 
improves exercise capacity （evidence level 1++）, 
dyspnea （evidence level 1++）, health status （evidence 
level 1++）, psychological functioning （evidence level 
1+）, and activities of daily living （ADL） （evidence 
level 1+）2）. The Global Initiative for Chronic Obstructive 
Lung Disease （GOLD） published in 2011, includes 
high level evidence for improved survival following 
high-intensity endurance training4）. The effects of 
endurance training described in many such guidelines 
are based on studies predominantly in people with 
Chronic Obstructive Pulmonary Disease （COPD）1-3）.
　The effects of endurance training in patients with 
interstitial lung disease （ILD） in particular idiopathic 
pulmonary fibrosis （IPF） have also been reported5-8）. 
Clinical management guidelines recommend that “the 
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Abstract　　High-intensity endurance training is mainly undertaken during pulmonary rehabilitation 
for patients with chronic respiratory disease. High-intensity endurance training is recommended in 
many clinical management guidelines. High-intensity endurance training involves training generally 
at an intensity of at 60-80％ of the patient’s peak work capacity or higher. The effects of high-intensity 
lower limb endurance training have mostly been investigated in chronic obstructive pulmonary disease 
（COPD） patients. High-intensity endurance training is more effective than low-intensity endurance 
training in terms of achieving physiologic gains. According to meta-analyses of studies in patients with 
chronic respiratory disease, this type of training results in improvements in range of exercise measures, 
health-related quality of life and dyspnea. There is also some evidence to support the benefits of high-
intensity endurance training patients suffering from chronic respiratory diseases other than COPD, such 
as in idiopathic pulmonary fibrosis and pulmonary arterial hypertension patient.
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majority of patients with IPF should be treated with 
pulmonary rehabilitation”9）. The Frequency, Intensity, 
Time, and Type （FITT Principle） are essential for 
when prescribing exercise training. In this review, we 
focus on the intensity component of exercise training 
in chronic respiratory diseases. However, the limits to 
exercises in different respiratory diseases may be 
different in themselves. For example in patients with 
COPD, exertional dyspnea is one of the main factors 
limiting. The mechanism for dyspnea in COPD is 
related to expiratory flow limitation and dynamic 
hyperinflation. Progressive dyspnea, hypoxaemia, 
frequently accompanied by a nonproductive cough; is 
the hallmark symptom and causes exercise limitation 
in patients with ILD. We focus in particular on the 
intensity of lower limb endurance training with a 
particular focus on studies in patients with COPD but 
also include data derived in patient populations with 
other chronic respiratory diseases.
2. High-intensity and low-intensity endurance 
training
　The characteristics of high and low-intensity are 
summarized in Table 1. High-intensity generally refers 
to exercising at between 60-80％ of peak work capacity, 
or on occasions at intensities in excess of this load. The 
load prescribed for low-intensity exercise is generally 
in the range of 40-60％ peak work capacity. There are 
several randomized controlled trials （RCTs） comparing 
high-intensity training and low-intensity training in 
patients with chronic respiratory disease.
　Casaburi et al. randomized 19 COPD patients to 
high-intensity or low-intensity training for a period of 
8 weeks with training taking place using a cycle 
ergometer on 5 days each week and examined the 
physiologic responses. The magnitude of improvement 
in physiologic responses was significantly greater in 
those who trained at a high-intensity. For example, 
minute ventilation （V・E）, heart rate （HR）, and blood 
lactate were all reduced by a significantly greater 
amount at submaximal workload following high 
intensity compared to low-intensity training10）. 
　Gimenez et al. randomized 13 COPD patients to 
high-intensity or moderate-intensity lower limb 
training daily for a period of 6 weeks11）. The physiologic 
measurements （e.g. peak V・O2 and anaerobic threshold） 
significantly improved by a greater amount in the 
high-intensity group. Further, during endurance 
exercise at a work load of 40 watts, dyspnea scores, 
blood lactate, V
・
E, respiratory rate （RR）, HR, and O2 
pulse significantly improved in the high-intensity 
group11）.
　Vallet et al. randomized 24 COPD patients to exercise 
at their HR achieved at the anaerobic or gas exchange 
threshold （high-intensity） or at a HR equivalent to 
50％ of maximal cardiac frequency reserve （low-
intensity）12）. In both groups, the program was carried 
out for 45 minutes, 5 times per week, for 4 weeks using 
a stationary cycle ergometer. Improved maximum 
oxygen uptake （peak V・O2） and O2 pulse were only 
observed in the high-intensity group, and V
・
E and blood 
lactate at any given V
・
O2 decreased by a greater 
magnitude in this group more than in the low-intensity 
group12）. Although these findings are derived from 
RCTs they include only a small number of patients, 
but do provide evidence of physiologic benefits following 
high-intensity lower limb endurance training. However, 
although high-intensity training has strong evidence 
of physiologic benefits, there are no robust data to 
determine whether high-intensity training has greater 
benefit on health-related quality of life （QOL）, dyspnea 
and ability to perform ADL, when compared to low or 
moderate-intensity training.
High intensity Low intensity 
Definition 60 to 80％ of peak V・O2 （peak work rate） 40 to 60％ of peak V
・
O2
 （peak work rate）
Advantages Large improvements in exercise capacity 
　during same exercise load, maximal 
　physiologic training effects
Easier to continue with this type of 
　training at home exercise
Low risk
Easier to maintain adherence
Disadvantages Not all patients can tolerate this training 
　intensity
Greater supervision required for risk 
　assessment
Poor adherence
Small improvement of exercise capacity
Need a long period to appear effect of 
　exercise training
Indication High motivation
No Cor pulmonale, serious arrhythmia, 
　and heart disease.






O2 ; oxygen consumption, SpO2 : oxyhemoglobin saturation measured by pulse oximetry
Table1.　High-intensity and low-intensity training
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3. High-intensity training in COPD patients
 1） Exercise capacity 
　Various measures of exercise capacity improve 
following high-intensity training in COPD patients. 
This is clinically important because exercise capacity 
（as measured by peak V・O2 and 6-minute walk distance 
（6MWD） is a stronger predictor of mortality than 
pulmonary functions or health-related QOL, and 
highlights the importance of evaluating exercise 
capacity in pulmonary rehabilitation programs.
　High-intensity training improves peak WR （peak 
work rate）, peak V・O2, anaerobic threshold, work 
efficiency, peak VT （peak tidal volume）, peak V
・
E 
（peak expiratory minute volume）, during incremental 
exercise capacity testing, and also improves the τ of 
V
・
O2 and exercise duration time in constant load 
exercise testing2,3,13,14）. Particularly, the reactivity of 
the effect of the exercise duration time in constant load 
exercise testing was excellent compared to various 
other exercise capacity measurements. Improvement 
of quadriceps force and work efficiency is involved in 
prolonged exercise duration time due to high-intensity 
training14）. The pathophysiologic abnormalities and 
possible mechanisms for improvement after exercise 
training of patients suffering from chronic respiratory 
disease including COPD patients are shown in Table 
215）. In clinical setting, dyspnea scores are used in order 
to adjust exercise intensity16,17）. This is possible because 
Table2.　Pathophysiologic abnormalities in patients with chronic respiratory disease and possible mechanisms 
　　　　  for improvement after exercise training
Pathophysiologic abnormality References Changes with exercise training References
Body composition Lower limb muscle cross-sectional 
area ↓ 
Fat-free mass ↓ 
Fat mass ↓ 
% fat- free mass ↓
54） Fat-free mass and fat mass with 
exercise and nutritional 
supplementation ↑ 
Fat-free mass and ↑ 
Fat mass with rehabilitation 
（resistance + endurance 
combined enhanced） ↓ 
Fat-free mass with testosterone and 
anabolic steroids ↑
55-57）
Lower limb muscle 
fiber type, size
% Fiber type I and myosin heavy 
chain （advanced disease） ↓ 
% Fiber type IIX ↑
 Fiber cross-sectional area linked to 
muscle atrophy ↓
58-64） Fiber-type proportion =　
Fiber cross-sectional area ↑
60）
Capillarization Capillary contacts to fiber cross-
sectional area, especially in 
patients developing fatigue during 
exercise ↓
60, 65） Capillary contacts proportional to 





Capacity of oxidative enzymes: 
citrate synthase, 3-hydroxyacyl-
coenzyme A dehydrogenase, 
succimic acid dehydrogenase, 
cytochrome c oxidase ↓　
Cytochrome c oxidase activity in 
hypoxemic patients ↑
65-67） Capacity of oxidative　enzymes 




Rest: intracellular pH ↓, 
Phosphocreatine and adenosine 
triphosphate ↓, lactate and inosine 
monophosphate ↑; glycogen stores 
in hypoxemic patients ↓; glycogen 
stores related to physical activity 
level ↓; uncoupling protein-3 
content ↓　
Exercise: rapid decline in muscle 
intracellular pH, phosphocreatine/
inorganic phosphate even in 
patients with relatively preserved 
submaximal oxygen delivery
60, 66, 69-73） Lactic acidemia at iso work rate
Normalization of decline in 







Inflammatory/apoptotic markers may 
occur in skeletal muscle in 
subpopulations of wasted COPD ↑
74, 75） No effect shown or not studied 
Redox state Glutathione levels normal to 
moderately reduced ↑　
Oxidative stress in the skeletal 
muscle of COPD patients after 
quadriceps exercise
61, 76-78） Oxidized gluthatione in contrast to 
observations in healthy subjects ↑




pH; potential hydrogen, COPD; chronic obstructive pulmonary disease
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of the strong association between dyspnea scores and 
exercise intensity. Accordingly, dyspnea scores are 
used to progress intensity throughout a training 
program18）. A dyspnea score of 4 to 6 using the Borg 
then constructed a category ratio 10 scale （the Borg 
CR10 Scale） or 12 to 14 using a Rating of Perceived 
Exertion ranging are considered the target for exercise 
training intensity17）. Alternatively, HR at the gas 
exchange threshold or specific training load has also 
been used12）.
　In the 2006 Cochrane review of exercise training in 
COPD19）, there were 13 trials of pulmonary rehabili-
tation that included high-intensity training with 
maximal exercise capacity as the outcome, and a meta-
analysis was carried out on 268 patients in the 
rehabilitation group and 243 patients in the usual care 
group （non-exercise control group）. The common effect 
（weighted mean difference [WMD]） for the change in 
maximum workload achieved on a maximal cycle 
ergometer test （peak WR） following training was 8.43 
watts （95％ CI: 3.4 to 13.4）. Another meta-analysis was 
carried out on data from 16 trials that used functional 
exercise capacity （as measured by 6MWD） as the 
outcome from 346 patients in the rehabilitation group 
and 323 patients in the usual care group. The common 
effect WMD for a 6MWD was 48.5m （95％CI: 32 to 65）. 
The minimum important difference （MID） of 6MWD 
was 54m for the average patient to stop rating 
themselves as "about the same" and start rating 
themselves as either "a little bit better" or "a little bit 
worse" （95％ CI: 37 to 71）20）. The common effect of the 
Cochrane review does not exceed MID. However, other 
meta-analysis reports21） analyzed that 6MWD is 55.7m 
（95％ CI: 27.8 to 92.8） as the effect in the rehabilitation 
group, which exceeds the MID. 11 trials （413 patients） 
were included in this analysis. After conversion back 
to natural units for the 6MWD, a difference in response 
between the treatment and control groups of 55.7m （95
％ CI: 27.8 to 92.8） was found. They estimated the 
minimal clinically important difference （MCID） of the 
walk test at about 50m from a study in which COPD 
patients rated their walking ability by subjective 
comparisons with one another. The limits of the CI for 
the pooled estimate of effect size （27.8 to 92.8） were 
wider than those of the estimate of the MCID of the 
6-min walk test （6MWT）（37 to 71）.
　Griffiths et al reported a study of 200 patients chronic 
lung disease patients （167 had COPD） were randomly 
assigned to 6 weeks multidisciplinary rehabilitation 
program or usual care that did not involve any exercise 
training22）. A program involving 30 minutes of walking 
at an intensity equivalent to 80％ of the maximum 
speed achieved at baseline on the incremental shuttle 
walk test （ISWT） was undertaken in the exercise 
training group, and, after 6 weeks, a difference of 
75.9m was observed in performance on the ISWT 
compared to the control group, leading to the conclusion 
that high-intensity walking training is effective22）. 
This improvement exceeds the MID for the ISWT 
which was reported as 47.5m23）.
 2） Health-related quality of life （QOL）
　In the 2006 Cochrane review, the effect of high-
intensity training was investigated using two health- 
related QOL measures19）. There were 11 RCTs that 
used the Chronic Respiratory Disease Questionnaire 
（CRQ）, with a meta-analysis carried out on data from 
326 patients in the rehabilitation group and 292 
patients in the usual care group （control）. The CRQ 
comprises the four domains of fatigue, emotional 
function, mastery, and dyspnea, all of which improved 
following training. The common effect （WMD） for 
fatigue was 0.92 （95％CI: 0.71 to 1.13）, emotional 
function was 0.76 （95％CI: 0.52 to 1.00）, and for mastery 
was 0.97 （95％CI: 0.74 to 1.20）. For the dyspnea domain, 
the meta-analysis included data from 323 patients in 
the rehabilitation group and 287 patients in the usual 
care group, with the WMD being 1.06 （95％CI: 0.85 to 
1.26）. All these changes exceeded the MID for CRQ 
scores is which has been determined as 0.5 points per 
item19）.
　There are 6 RCTs that used the St Georges 
Respiratory Questionnaire （SGRQ）, with meta-
analysis carried out using data from 196 patients in 
the rehabilitation group and 188 patients in the usual 
care group. SGRQ comprises the domains of, symptoms, 
impacts, and activity, and provides a total score19）. The 
common effect （WMD） for the total score was -6.11 
 （95％CI: -8.98 to -3.24）, symptoms was -4.68 （95％CI: 
-9.61 to 0.25）, impacts was -6.27 （95％CI: -10.08 to -2.47）, 
and activity was -4.78 （95％CI: -7.83 to -1.72） with all 
these changes exceeding the MID for this scale which 
is 4 points24）. The COPD assessment test （CAT） is a 
health status measure that has recently started to be 
used to determine responses to pulmonary rehabili-
tation25-27）.
 3） Physical activity
　Physical activity is an independent prognostic factor 
for mortality and hospitalization due to severe 
exacerbations in COPD patients28,29）. A recent systematic 
review and meta-analysis of studies of exercise training 
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was unable to find any published RCTs examining the 
effect of exercise training compared with usual care30）. 
The authors included a total of 7 studies, 2 randomized 
trials and 5 single-group interventional studies31,32）. 
They concluded that current data suggest supervised 
endurance training may lead to a small but significant 
effective on physical activity31）.
4. High-intensity training in in respiratory 
diseases other than COPD
　Although there are very clear evidence-based 
guidelines regarding exercise training for COPD 
patients, in contrast there are many less reports 
pertaining to the benefits of exercise training, and in 
particular recommended training intensity, in 
patients with other chronic respiratory diseases33）. In 
the following sections we have summarized the results 
of studies of effects of endurance training in patients 
with other respiratory diseases other than COPD
 1） Interstitial lung disease （ILD）
　A Cochrane systematic review reported 2 RCTs of 
effect of exercise training in ILD and interstitial 
pneumonia （IP）7）. High-intensity exercise training is 
used in pulmonary rehabilitation programs for ILD 
and IPF patients5,8）. 2 trials provided sufficient data 
using 6MWD for meta-analysis, with a total of 43 
participants in the exercise training group and 42 
participants in the control group7,8）. The common effect 
（WMD） for change in distance walked was 38.6m in 
favor of the exercise training group （95％ CI: 55.4 to 
61.9）. The common effect （standardized mean difference） 
for change in dyspnea was -0.47 in favor of the exercise 
training group （95％ CI: -0.91 to -0.04）. There was a 
common effect indicating an improvement in QOL 
with exercise training （standardized mean difference 
0.58, 95％ CI: 0.15 to 1.02）. 
　The magnitude of these benefits was smaller than 
that generally seen in COPD7,34）. Kozu et al. reported 
that PR produced smaller improvements in 6MWD in 
IPF patients than in COPD patients34）. They measured 
exercise capacity by 6MWT for the benefits of high-
intensity endurance exercise training. Furthermore 
Arizono et al. reported that endurance time showed 
the most striking improvement than peak WR, 6MWD 
and the incremental shuttle walk distance （ISWD） by 
evaluating the efficacy of high-intensity endurance 
exercise training in IPF patients. The effect size of 
endurance time was as large as 2.9635）. The improvement 
in endurance time was significantly correlated with 
change in the anaerobic threshold and work efficiency.
 2） Cystic fibrosis 
　Exercise training is now an essential component of 
the management of patients with cystic fibrosis （CF）36）. 
A Cochrane systematic review included 28 studies 
examining the effect of exercise training in patients 
with CF. Most of the trials that prescribed training in 
accordance with recommendations from the American 
College of Sports Medicine, （i.e. exercising for a 
tolerable time and aiming to progress to at least 20 to 
30 minutes exercise at each session, at 55％ to 64％ 
maximum HR, on 3 to 5 days a week） demonstrated 
that training was beneficial37）. Substantial evidence 
now confirms that exercise training significantly 
reduces the rate of decline in lung function in CF 
patients, at least in part by enhancing mucus 
clearance38）. Exercise training has beneficial effects in 
CF patients with regard to the preservation and 
improve pulmonary function, exercise capacity, muscle 
strength and QOL, and reducing morbidity and 
mortality39）． 
 3） Non-CF bronchiectasis
　Peripheral muscle endurance, exercise capacity, 
fatigue and health status are adversely affected by in 
patients with non-CF bronchiectasis40）. Newell et al. 
investigated the effects of exercise training in 32 
patients with idiopathic bronchiectasis who were 
randomly allocated to one of three groups （pulmonary 
rehabilitation plus sham inspiratory muscle training, 
pulmonary rehabilitation plus 60％ inspiratory muscle 
training of maximum inspiratory pressure and 
control）. The patients underwent 8 weeks training 
program with exercise performed 3 times each week at 
an intensity equivalent to 80％ of the peak HR. Patients 
assigned to the exercise training groups demonstrated 
significant increases in performance on the ISWT 
equivalent to a change of 96.7m （95％ CI: 9.6 to 
133.7）41）. In this study, exercise training resulted in 
improvements in exercise capacity of a similar in 
magnitude to that seen in patients with COPD41）. 
Furthermore, Lee et al. reported that patients with 
non-CF bronchiectasis were randomly allocated to 8 
weeks of supervised exercise training. Exercise 
training was included treadmill or land based walking, 
with the initial intensity set to 75％ of the maximal 
speed achieved on ISWT, stationary cycling prescribed 
at 60％ of maximal WR for cycling. Exercise training 
group increased the ISWD （mean difference to control 
62m, 95％ CI: 24 to 101） and 6MWD （mean difference to 
control 41m, 95％ CI: 19 to 63）42）. However, there are 
few reports of the exercise training in non-CF 
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bronchiectasis, and more evidence is required43）． 
 4） Asthma
　Exercise training as part of pulmonary rehabilitation 
is provided to patients with asthma as well as those 
with COPD． Turner et al. investigated the effects of 
exercise training in 34 patients with asthma were 
randomly allocated to 6 weeks period of supervised 
exercise training or a non-exercise control group44）. 
Training was performed 3 times each week at an initial 
intensity equivalent to 80％ of the average walking 
speed achieved on the 6MWT. In this study, 6MWD 
increased by an average 36 minutes the exercise group44,45）. 
There is some evidence to suggest that exercise training 
may reduce airway inflammation in asthmatics46）. 
Furthermore, the pre-exercise use of inhaled broncho-
dilators and a gradual warm-up are recommended to 
minimize exercise-induced bronchospasm3）.
 5） Pulmonary arterial hypertension
　A study protocol reported whether outpatient-based, 
whole body high intensity exercise training is beneficial 
and safe in individuals with pulmonary arterial 
hypertension47）. Intensity for the lower limb endurance 
exercise was prescribed with the aim of achieving 60- 
70％ HR max （based on age predicted maximum, 220- 
age）, while maintain SpO2 （oxyhemoglobin saturation 
measured by pulse oximetry） ≧ 92％ and symptom 
intensity （Borg CR10 scale < 4 and Rating of Perceived 
Exertion （RPE） < 4）. Mereles et al. investigated that 
the prospective randomized study to evaluate the 
effects of exercise and respiratory training in patients 
with severe symptomatic pulmonary arterial 
hypertension. The exercise training consisted of an 
interval training using a cycle ergometer with intensity 
prescribed at a workload equivalent to 60 to 80％ of 
peak HR. The exercise group underwent 15 weeks 
training program. The mean ± standard deviation 
improvement in 6MWD in the group who trained was 
96 ± 61m48）. Furthermore there are 2 RCTs that 6MWD 
was used as outcome in pulmonary hypertension49,50）. 
Ley et al. investigated the effects of exercise training 
in 20 patients were randomly allocated to 3 weeks 
period of supervised exercise training. Training was 
performed an initial intensity 60-80％ of HR max. In 
this study, 6MWD increased average 91m in the 
exercise group50）. Westein et al. reported that 24 
patients with pulmonary hypertension were randomized 
into 10 weeks program that consisted of patient 
education only or patient education plus aerobic 
exercise training. The intensity was 70-80％ of HR max. 
Patients receiving aerobic exercise training plus 
education resulted in a 53m increase in 6MWT49）. 
Exercise training in this patient population seems to 
be a promising adjunct to medical treatment and may 
have benefits in terms of survival in patients with 
chronic thromboembolic pulmonary hypertension51）.
 6） Sequelae of tuberculosis
　The benefit of exercise training in patients of 
sequelae of tuberculosis appear to be similar to we 
reported in people with COPD. Ando et al performed a 
prospective nonrandomized open trial over 9 weeks 
period52）. 32 patients with sequelae of tuberculosis and 
age and forced expiratory volume in one second （FEV1） 
matched COPD patients were enrolled in the study. 
During the high-intensity walking training, each 
patient was instructed to walk at > 90％ of their 
baseline 6MWT speed. To maintain the selected speed, 
patients were instructed to cover the prescribed 
number of rounds of the circuit within a 15 minute 
period. Following training, 6MWD improved by an 
average of 40m （sequelae tuberculosis patients 42m, 
COPD patients 47m）. This study showed that the 
magnitude of improvement in 6MWD following 9 weeks 
pulmonary rehabilitation program was similar in both 
patient groups and further, the improvement in 
6MWD was maintained for 6 months after the 
termination of the pulmonary rehabilitation program 
in both groups52）. 
　Yoshida et al. investigated the effects of exercise 
training in 14 patients with stable sequelae of 
tuberculosis53） The patients were instructed to perform 
daily walking training in a hallway within the hospital 
for 2 weeks. The training commenced at an intensity 
equivalent to the patients’ maximum walking speeds 
achieved during a baseline treadmill test. The training 
was started their maximum walking speed during the 
treadmill test. Exercise tolerance improved following 
training as demonstrated by a significant increase 
in peak oxygen uptake （1.2ml/kg/min） and 6MWD 
（68m） 53）.
5. Conclusion
　High-intensity lower limb endurance training in 
patients with chronic respiratory disease including 
COPD significantly improves exercise capacity, dyspnea, 
and health-related QOL. High-intensity training is 
associated with a greater magnitude of physiologic 
response than low -intensity training; however, there 
is less evidence to support greater benefits in symptoms 
and health-related QOL with high versus low-intensity 
training. Evidence demonstrating the efficacy of high-
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intensity endurance training in patient populations 
other than COPD, for example ILD, cystic fibrosis, 
asthma and pulmonary arterial hypertension is being 
accumulated.
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